ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,020Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 680

$1.65M Total Retail Price of All Prescriptions

Rank: 15 out of 680

674 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 674 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

32% of this provider’s 674 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 20,700 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,451 873 S3 1 4
AMLODIPINE BESYLATE 1,005 724 2 1
FUROSEMIDE 929 686 3 6
LEVOTHYROXINE SODIUM 805 668 4 2
SIMVASTATIN 793 569 5 3
LISINOPRIL 707 498 6 5
OMEPRAZOLE 620 433 7 7
METFORMIN HCL 510 368 8 8
NEXIUM 485 298 9 16
POTASSIUM CHLORIDE 482 299 10 14
SERTRALINE HCL 426 307 11 28
WARFARIN SODIUM 400 357 12 20
METOPROLOL SUCCINATE 386 308 13 13
HYDROCHLOROTHIAZIDE 385 287 14 9
METOPROLOL TARTRATE 362 250 15 12
ZOLPIDEM TARTRATE 334 207 16 17
GABAPENTIN 312 165 17 15
CARVEDILOL 304 194 18 23
LANTUS 292 230 19 49
ATORVASTATIN CALCIUM 290 189 20 11
TAMSULOSIN HCL 288 196 21 34
PROAIR HFA 287 163 22 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 271 201 23 37
CLOPIDOGREL 263 190 24 26
CARISOPRODOL 251 77 R 25 83
AZITHROMYCIN 248 175 26 42
TRAMADOL HCL 240 183 27 18
OXYCODONE-ACETAMINOPHEN 236 183 S2 28 215
ALLOPURINOL 223 192 29 33
METHYLPREDNISOLONE 221 156 30 93
CIPROFLOXACIN HCL 221 180 30 57
NAMENDA 218 212 32 35
PLAVIX 217 166 33 39
CLONIDINE HCL 213 140 34 36
RANITIDINE HCL 210 146 35 56
AMITRIPTYLINE HCL 200 112 R 36 47
ALENDRONATE SODIUM 199 124 37 32
CITALOPRAM HBR 195 122 38 22
DIOVAN 192 153 39 31
CYMBALTA 185 126 40 46
CRESTOR 178 101 41 25
DONEPEZIL HCL 174 170 42 27
PRAVASTATIN SODIUM 173 129 43 10
RISPERIDONE 171 151 44 80
POLYETHYLENE GLYCOL 3350 166 139 45 62
PANTOPRAZOLE SODIUM 163 117 46 30
MELOXICAM 163 115 46 24
TRIAMCINOLONE ACETONIDE 159 106 48 199
QUETIAPINE FUMARATE 157 83 49 64
GLYBURIDE-METFORMIN HCL 153 120 R 50 107
ESCITALOPRAM OXALATE 150 107 51 45
DIGOXIN 148 105 52 58
ISOSORBIDE MONONITRATE ER 147 131 53 59
AMLODIPINE BESYLATE-BENAZEPRIL 146 91 54 43
LYRICA 143 82 55 77
PREDNISONE 142 120 56 50
CYCLOBENZAPRINE HCL 136 41 R 57 81
LOVAZA 135 58 58 119
NAPROXEN 134 76 59 121
MIRTAZAPINE 132 80 60 78
SINGULAIR 131 112 61 91
LEVOFLOXACIN 130 92 62 97
MUPIROCIN 130 77 62 130
NIFEDIPINE ER 121 105 64 75
MEGESTROL ACETATE 120 105 R 65 88
FENOFIBRATE 119 85 66 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 118 84 67 94
BYSTOLIC 116 40 68 79
PHENYTOIN SODIUM EXTENDED 116 65 68 115
TRAZODONE HCL 114 69 70 48
FINASTERIDE 111 104 71 109
ZETIA 108 84 72 87
DIVALPROEX SODIUM 107 35 73 110
THEOPHYLLINE ANHYDROUS 107 81 73 285
GLIMEPIRIDE 106 77 75 29
DIVALPROEX SODIUM ER 104 0 76 148
DOXYCYCLINE HYCLATE 103 71 77 95
NITROFURANTOIN MONO-MACRO 103 86 77 172
TRICOR 102 54 79 98
DIOVAN HCT 102 77 79 55
AVODART 99 64 81 218
JANUVIA 99 88 81 60
LIPITOR 98 59 83 68
COMBIVENT 96 78 84 168
ABILIFY 94 74 85 178
NOVOLOG 93 72 86 167
NOVOLIN R 92 75 87 113
RAMIPRIL 91 79 88 69
SPIRIVA 90 76 89 70
ROPINIROLE HCL 89 76 90 99
NYSTATIN 89 71 90 191
VENTOLIN HFA 85 47 92 202
IBUPROFEN 85 68 92 126
CELEBREX 84 32 94 90
ATENOLOL 83 66 95 19
DETROL LA 82 74 96 169
FLUCONAZOLE 82 49 96 139
TRIAMTERENE-HCTZ 81 59 98 52
GLYBURIDE MICRONIZED 81 70 R 98 232
DILTIAZEM ER 80 61 100 165
HYDRALAZINE HCL 80 47 100 71
SPIRONOLACTONE 79 63 102 82
PREMARIN 77 60 R 103 105
MONTELUKAST SODIUM 77 69 103 157
ADVAIR DISKUS 76 66 105 53
BUPROPION XL 75 48 106 161
INSULIN SYRINGE 72 56 107 86
HUMULIN R 72 56 107 195
ENALAPRIL MALEATE 72 38 107 65
MISOPROSTOL 70 45 110 341
METRONIDAZOLE 67 57 111 306
VENLAFAXINE HCL ER 67 31 111 101
VYTORIN 67 47 111 152
HUMALOG 66 32 114 196
KETOCONAZOLE 65 32 115 219
QUINAPRIL HCL 65 33 115 104
LABETALOL HCL 64 63 117 158
LOSARTAN POTASSIUM 64 60 117 21
AGGRENOX 63 58 119 177
FLUOXETINE HCL 62 42 120 74
LOVASTATIN 62 48 120 44
FENTANYL 62 44 S2 120 183
CEPHALEXIN 62 33 120 149
METOCLOPRAMIDE HCL 62 35 120 118
VERAPAMIL ER 59 50 125 100
SEROQUEL 59 32 125 123
FLUTICASONE PROPIONATE 59 48 125 41
VOLTAREN 59 36 125 253
DICLOFENAC SODIUM 58 31 129 162
DOXEPIN HCL 58 42 129 200
CARBIDOPA-LEVODOPA 58 49 129 117
PEN NEEDLE 57 39 132 122
NASONEX 56 39 133 197
CLOTRIMAZOLE-BETAMETHASONE 56 41 133 138
OXYCODONE HCL-ACETAMINOPHEN 55 12 S2 135 133
ISOSORBIDE DINITRATE 55 39 135 227
LANSOPRAZOLE 54 33 137 184
NABUMETONE 54 13 137 174
LANTUS SOLOSTAR 54 34 137 84
DILTIAZEM 24HR ER 54 28 137 132
CLINDAMYCIN HCL 53 17 141 243
FAMOTIDINE 53 37 141 89
BACLOFEN 52 22 143 140
MORPHINE SULFATE ER 52 25 S2 143 198
METOLAZONE 51 33 145 201
ALPRAZOLAM 51 42 145 72
LEXAPRO 50 34 147 128
ACETAMINOPHEN-CODEINE 50 47 S3 147 175
AMOXICILLIN 50 29 147 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.